What is operator-led biopharma consulting?

Operator-led biopharma consulting means advisory services delivered by executives who have actually run pharma and biotech companies — not just advised them. Katogen's founder has led 17 acquisitions and raised over USD 4 billion, bringing hands-on operational insight to every engagement.

What types of companies does Katogen advise?

Katogen works with growth-stage and mid-sized life sciences companies seeking strategic guidance on M&A, capital raising, commercial strategy, biosimilars, novel modalities, drug delivery, supply chain, and reimbursement challenges.

What biopharma challenges does Katogen specialize in?

Katogen specializes in strategic planning, M&A integration, capital raises, novel modalities, generics and biosimilars, drug delivery innovation, supply chain optimization, and reimbursement strategy for growth-stage and mid-sized biopharma companies.

How do I start working with Katogen?

The best starting point is a direct conversation. Reach out through the contact page at katogen.com/contact and we will schedule an initial call to understand your situation and determine where we can add the most value.

Katogen | Operator-Led Biopharma Consulting & Advisory

Katogen is a biopharma consulting and advisory firm founded in 2016 and headquartered in Boston, MA. The firm is led by its founder, a biopharma executive with 35+ years of operator experience, including CEO roles at Alvogen - a global generics and specialty pharma company - and Cybin, a clinical-stage psychedelic medicine company. The founder has completed 17 acquisitions and raised over USD 4 billion in growth capital across the biopharma sector.

Katogen advises CEOs, founders, and executive teams at growth-stage and mid-sized biopharma and life sciences companies on strategic planning, M&A integration, capital raises, novel modalities, drug delivery, supply chain, and reimbursement strategy.

Operator-Led Biopharma Consulting: Transforming Vision Into Value

Learn more

Helping Companies Transform Vision into Value

Operator-Led Biopharma Consulting: Transforming Vision Into Value